Ringworm Bush's Laxative Effect and Anthraquinone Chemistry

State the finding before the mechanism, because it is the least expected one on this entire five-page set: the single best piece of clinical evidence for any use of this plant is not the antifungal claim it is named for. It is a 1990 Thai randomised controlled trial showing it works as a laxative — the one property this site's own main page on ringworm bush warns readers away from swallowing. That is not a contradiction. It is exactly what this page is about: one chemical family, the anthraquinones, producing a genuine and measurable effect that is a benefit when it is the object of the study and a hazard when it happens as a side effect of using the plant for something else.

The Trial: A Real Three-Arm RCT for Constipation
Mechanism: How an Anthraquinone Glycoside Becomes a Laxative
Quantifying the Chemistry: How Much Anthraquinone Is Actually in a Leaf
One Mechanism, Two Faces: Benefit and Hazard From the Same Compounds
A Real-World Parallel: Rhein Already Became a Drug
A Check This Page Ran and Rejects
A Genotoxicity Signal Worth Reporting Precisely
The Safety Consequences of Chronic Internal Use
What Is Not Known
Key Research Papers
Connections

The Trial: A Real Three-Arm RCT for Constipation

In 1990, a multicentre team based at Siriraj Hospital, Mahidol University, ran a randomised controlled trial of Cassia alata leaves for constipation across one provincial and five community hospitals in Thailand — a genuinely rigorous design for a plant remedy of this era. Eighty adult patients with at least 72 hours of constipation were randomised to three arms: placebo (n=28, a caramel-coloured fluid), mist. alba (n=28, a traditional milk-of-magnesia-type comparator mixture already in clinical use), or Cassia alata leaf infusion (n=24). Each patient received 120 mL of the assigned fluid at bedtime, and defecation within 24 hours was the endpoint.

The result: 18 per cent of the placebo group passed stool within 24 hours, versus 86 per cent of the mist. alba group and 83 per cent of the Cassia alata group — both active arms significantly better than placebo (P < 0.001) and, by the reported figures, statistically indistinguishable from each other. Minimal self-limited side effects — nausea, dyspepsia, abdominal pain, diarrhoea — occurred in 16–25 per cent of patients across the groups (Thamlikitkul et al., 1990, Journal of the Medical Association of Thailand). The published abstract is truncated before giving the exact leaf-to-water ratio used to prepare the infusion, so this page will not guess at a gram dose from it — but the trial design itself, with a real placebo arm and an active comparator already in clinical use, is stronger than almost anything else reported anywhere in this five-page set, including the antifungal claim the plant is famous for.

This is worth sitting with for a moment, because it inverts the usual pattern on this site. Most herb pages report a famous traditional claim with thin human data and a minor, barely-mentioned side effect with better data behind it by accident. Here, the plant's dominant public identity — "ringworm bush" — is the claim with uncontrolled, partial human evidence (see the antifungal page), while the property everyone is warned away from using is the one with an actual randomised trial behind it. Neither fact changes the practical advice below, which is still not to use this plant as a home laxative — but the reason is not "there's no evidence it works." It works. The reason is what follows.

Mechanism: How an Anthraquinone Glycoside Becomes a Laxative

The leaves contain anthraquinones bonded to sugar molecules — anthraquinone glycosides. In that glycoside form, the compounds are too polar to be absorbed across the small intestine, so they travel essentially intact into the colon. There, resident gut bacteria cleave off the sugar, releasing the active anthrone/anthraquinone aglycone. The freed compound does two things at the colon wall: it stimulates propulsive smooth-muscle contraction, and it alters the balance of water and electrolyte transport across the colonic lining so that less water is reabsorbed from the stool. The six-to-twelve-hour delay this bacterial-activation step requires is why anthraquinone laxatives — this plant, pharmaceutical senna, cascara, rhubarb root — characteristically act the following morning rather than within the hour. It is the identical mechanism behind the pharmaceutical laxative senna, covered in full on this site's Senna page, which is built from a different but closely related species, Senna alexandrina.

Quantifying the Chemistry: How Much Anthraquinone Is Actually in a Leaf

Unlike most of the numbers on the site's herb pages, this compound family has actually been measured with a validated analytical method. A Thai pharmacognosy group developed and validated an HPLC method to simultaneously quantify all four of the plant's named anthraquinones — rhein, aloe-emodin, emodin and chrysophanol — in Senna alata leaves. Using an extraction solvent optimised specifically to maximise yield (5% hydrochloric acid, 5% ferric chloride and 15% water in methanol), they recovered up to 1.67% w/w total anthraquinone content from the leaf extract (Panichayupakaranant et al., 2009). That figure describes a chemically enhanced extraction designed to pull out as much anthraquinone as possible, not a simple household decoction, so this page will not translate it into a "safe" or "effective" gram dose of leaf — the RCT above used an infusion of unstated strength, and no study has connected a specific leaf weight to a specific anthraquinone dose to a specific clinical effect. What the figure does establish is that the compound family is present at a concentration high enough to be pharmacologically plausible at the kind of leaf quantities traditional preparations use, which is the most that can honestly be said.

Two further analytical studies confirm rhein and aloe-emodin specifically as the dominant anthraquinones by HPTLC (thin-layer chromatography) in Thai-sourced leaves and commercial products (Chewchinda et al., 2017), and alongside emodin in a comparison against the related plants Rheum emodi (Indian rhubarb) and Aloe species (Narayanan et al., 2015) — a useful reminder that this same small family of anthraquinone compounds recurs across several unrelated laxative and dermatological plants. A later study optimised microwave-assisted extraction specifically to maximise anthraquinone and flavonoid yield for research purposes (Yeong et al., 2022).

One Mechanism, Two Faces: Benefit and Hazard From the Same Compounds

This is the point the whole page has been building to, and it deserves to be stated as plainly as the doctrine this site follows requires: when a claimed benefit and a documented hazard trace to the same mechanism, say so directly rather than treating them as two separate stories. Here, they are one story told twice.

Aloe-emodin — one of the same four anthraquinones quantified above, and the same compound whose laxative action is described in this section — is also the single most active MRSA-inhibiting compound identified from this plant's leaves, with a measured MIC₅₀ of 12.0 ± 1.5 µg/mL (covered in full on the antibacterial page). The same lipophilic, membrane-active property that plausibly helps disrupt a fungal or bacterial cell membrane when the compound is applied to skin is, chemically, unrelated to why it stimulates the colon after bacterial cleavage in the gut — but both effects come from the same short list of four compounds, extracted from the same leaf, and a product that concentrates one concentrates the other. A cream or lotion applied to skin does not reach the colon in meaningful amounts and does not raise laxative risk. A capsule, tea or "detox" product made from the same leaf carries both properties whether the seller intends it or not.

A Real-World Parallel: Rhein Already Became a Drug

Rhein is not only one of this plant's four anthraquinones; it is also the active metabolite of diacerein, a pharmaceutical used in some countries (though not FDA-approved in the United States, and restricted in the European Union over safety concerns) for slow-acting symptom relief in osteoarthritis. The parallel is instructive in both directions. On one hand, it is a concrete demonstration that this compound family has genuine, clinically meaningful biological activity — not merely a laboratory curiosity. On the other hand, diacerein's own best-documented and most common adverse effect in the clinical-trial and pharmacovigilance record is diarrhoea, occurring in a substantial minority of patients — which is simply this same anthraquinone/colonic mechanism showing up as a side effect in a drug developed for an entirely unrelated joint condition. The lesson transfers directly: a rhein-family compound taken in any concentrated, standardised form should be expected to affect the bowel, whether or not that is the reason someone is taking it.

A Check This Page Ran and Rejects

Several herb pages on this site have had to correct a common but mechanistically backwards assumption: that any plant "containing coumarins" is therefore a blood-thinner. That specific error does not apply here — ringworm bush's documented chemistry is anthraquinones and flavonoids, not coumarins or furanocoumarins, and no source reviewed for this page reports coumarin content in this species. The relevant caution for anticoagulated patients on this plant runs through a different and better-supported route instead: chronic diarrhoea from any cause, including a stimulant laxative, alters vitamin K absorption and can swing a patient's INR on warfarin. That is a real, mechanistically sound caution; a coumarin-content warning would not have been (background: dicoumarol and sweet-clover disease, the actual coumarin-derived anticoagulant, for contrast).

A Genotoxicity Signal Worth Reporting Precisely

Two related laboratory papers from the same Brazilian research group are worth reporting exactly as they were run, neither inflated nor ignored. First, a purified, concentrated leaf fraction showed a strong DPPH free-radical-scavenging signal (IC₅₀ = 2.27 µg/mL) and no pro-oxidant activity in a yeast model — but its major HPLC component, identified as astragalin (kaempferol-3-O-glucoside), was shown by spectroscopy and computational docking to bind directly to DNA, intercalating at G-C base pairs (Saito et al., 2012, International Journal of Molecular Sciences). Second, a related antibacterial fractionation study from the same group, covered in more depth on the antibacterial page, ran the standard Ames bacterial-mutagenicity assay across five tester strains and found weak mutagenicity (mutagenic index below 3, the standard threshold) in exactly one of them (Saito et al., 2012, Evidence-Based Complementary and Alternative Medicine).

What this is, and is not. This is a real laboratory signal in a purified, concentrated fraction — not a demonstrated human carcinogenicity risk, not a case report of harm in anyone who has used this plant, and not correlated with any clinical outcome in the decades this plant has been used topically and, in the Thai trial above, taken by mouth without any such signal being reported. It is a specific, bounded finding: a weak positive in one of five standard bacterial tester strains, plus in-vitro DNA binding by one purified flavonoid glycoside. It adds one more concrete reason, alongside the electrolyte and dependence risks below, to avoid concentrated, chronic internal use of this plant — a conclusion this page would reach anyway on GI-safety grounds alone — and it is not a reason for concern about the topical traditional use, where systemic absorption is minimal.

The Safety Consequences of Chronic Internal Use

The main article covers dosing and contraindications in full; this section adds the mechanistic detail behind two of those cautions specifically, because both trace directly to the chemistry above.

Potassium loss. Chronic stimulant-laxative use is a well-documented cause of hypokalaemia (anthraquinone laxatives and potassium loss), and low potassium is exactly the condition that makes digoxin dangerously more potent — a specific, well-characterised drug interaction (digoxin and hypokalaemia toxicity). Anyone on digoxin, a diuretic, or a corticosteroid has a materially higher-stakes reason to avoid unstandardised internal use than someone who is not.
Melanosis coli. Long-term anthraquinone exposure visibly darkens the colonic lining — a harmless but distinctive pigmentation seen at colonoscopy, and a marker of chronic stimulant-laxative use rather than a disease in itself (melanosis coli and chronic anthraquinone laxative use). It is included here because it is direct, visible evidence that a chronically used anthraquinone laxative reaches and affects colonic tissue exactly as the mechanism above predicts.
Dose unpredictability. Unlike a standardised senna tablet, leaf anthraquinone content varies with plant, season and drying method (see the quantification section above), so the same household preparation can be markedly weaker or stronger from one batch to the next.

What Is Not Known

The Thai RCT's exact infusion strength is not recoverable from the published abstract, so no gram-to-effect dose can be stated for this plant specifically, only for anthraquinones as a class.
No modern trial has replicated the 1990 result with contemporary methodology, a standardised extract, or a larger sample.
No human pharmacokinetic study has measured how much of the leaf's anthraquinone glycoside content actually reaches the colon intact versus is lost to other gut processes.
The clinical significance of the weak Ames signal and the astragalin-DNA binding finding is untested — both are laboratory observations in purified fractions, not findings connected to any outcome in a person who has used this plant.
No study has compared this plant's laxative effect against standardised pharmaceutical senna head-to-head, only against a placebo and a milk-of-magnesia-type comparator.

Key Research Papers

Connections

All Herbs
Ringworm Bush (Senna alata) — the main article, with full dosage and contraindication detail.
Ringworm Bush Benefits Deep Dive — the hub for this set.
Antifungal Activity and Ringworm Treatment — the plant's famous claim, with weaker evidence than this one.
Antibacterial Activity and Skin Infections — more on aloe-emodin's antimicrobial data.
Senna (Senna alexandrina) — the standardised pharmaceutical laxative built from the closely related species this plant is constantly confused with.
Aloe Vera — another anthraquinone-bearing plant with the same soothing-versus-laxative split between its parts.
Osteoarthritis — diacerein's actual approved indication.
Cardiology — for background on digoxin and potassium-sensitive arrhythmia risk.
Potassium — the mineral depleted by chronic stimulant-laxative use.

Back to Table of Contents